Comments on "Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis"

Comment

Kai Zhang et al. Pancreas. 2020 Oct.

. 2020 Oct;49(9):e80-e81.

doi: 10.1097/MPA.0000000000001638.

No abstract available

Comment in

Reply.
Rossi RE, Massironi S. Rossi RE, et al. Pancreas. 2020 Oct;49(9):e81-e82. doi: 10.1097/MPA.0000000000001639. Pancreas. 2020. PMID: 33003090 No abstract available.

Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis.
Rossi RE, Ciafardini C, Sciola V, Conte D, Massironi S. Rossi RE, et al. Pancreas. 2018 Nov/Dec;47(10):1249-1255. doi: 10.1097/MPA.0000000000001184. Pancreas. 2018. PMID: 30325865

1. Rossi RE, Ciafardini C, Sciola V, et al. Chromogranin A in the follow-up of gastroenteropancreatic neuroendocrine neoplasms: is it really game over? A systematic review and meta-analysis. Pancreas. 2018;47:1249–1255.
1. Bramer WM, Rethlefsen ML, Kleijnen J, et al. Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study. Syst Rev. 2017;6:245.
1. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [Internet]. The Cochrane Collaboration. 2011. Available at https://handbook5-1.cochrane.org/. Accessed June 15, 2018.
1. Bramer WM, Giustini D, Kleijnen J, et al. Searching Embase and MEDLINE by using only major descriptors or title and abstract fields: a prospective exploratory study. Syst Rev. 2018;7:200.
1. Lam MT, De Longhi C, Turnbull J, et al. Has Embase replaced MEDLINE since coverage expansion?J Med Libr Assoc. 2018;106:227–234.